HOME >> BIOLOGY >> NEWS
Researchers identify molecule that senses osmotic pressure in vertebrates

Findings may provide insight into biological basis of inner ear function and sense of touch

Researchers at the Howard Hughes Medical Institute and Rockefeller University have identified a molecule in vertebrates that senses osmotic pressure -- the measure of saltiness essential for living cells -- and may provide an inroad into understanding inner ear function and the sense of touch. The findings are reported in the October 27 issue of Cell.

The molecule, called VR-OAC (Vanilloid Receptor-related Osmotically Activated Channel), is an ion channel that responds to changes in osmotic pressure of extracellular fluid. Osmotic pressure is the pressure exerted by salts and proteins dissolved in bodily fluids. When osmotic pressure outside a cell decreases, this leads to an increased tension in a cell's membrane, like the tension in a balloon as it is inflated, a physical stimulus which in turn opens up the channel, allowing ions, among them calcium ions, to pass through, which elicits a cascade of intracellular events. In the case of sensory cells and nerve cells, this is converted into electrical signals to the central nervous system. The scientists cloned VR-OAC from rat, mouse, chicken and human gene libraries. The ion channel was detected in cells from the inner ear, the osmoregulator centers of the brain in the hypothalamus and from cells surrounding whiskers, a rodent's snout hair known to be very sensitive to touch. The presence of VR-OAC in the latter cells suggests that this receptor may also be involved in the sense of touch.

The research was led by Wolfgang Liedtke, M.D., a research associate in the Laboratory of Molecular Genetics headed by Jeffrey M. Friedman, M.D., Ph.D., an investigator at the Howard Hughes Medical Institute, and Stefan Heller, Ph.D., a former postdoctoral researcher in the Laboratory of Sensory Neuroscience at Rockefeller headed by A. James Hudspeth, M.D., Ph.D., also an investigator at the Howard
'"/>

Contact: Joseph Bonner
bonnerj@mail.rockefeller.edu
212-327-7900
Rockefeller University
25-Oct-2000


Page: 1 2 3

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/14/2018)... ... December 14, 2018 , ... uBiome, ... “Method and System for Microbiome-Derived Diagnostics and Therapeutics” by the US Patent and ... 2014. The patent is an invention by uBiome collaborators Dr. Zachary Apte, Dr. ...
(Date:12/13/2018)... Fla. (PRWEB) , ... December 12, 2018 , ... New ... preventing the growing problem of drowsy and distracted driving, one of the main causes ... under the guidance of Dr. Kanwal Gagneja , assistant professor of computer science, ...
(Date:12/5/2018)... ... December 05, 2018 , ... Surgical Theater brings ... TN, from December 6-9, 2018 at booth #312. AANS/CNS provides Pediatric Neurosurgeons an ... the treatment continuum – from the consultation, to surgical planning, and into the ...
Breaking Biology News(10 mins):
(Date:1/10/2019)... ... ... Rascal was adopted from a local shelter when he was around two years old. ... six weeks after he was adopted, he tore his right cruciate ligament. Though he ... after such a traumatic injury. , Sure enough, when Rascal was about nine years old, ...
(Date:1/7/2019)... ... January 07, 2019 , ... Kainos ... its Parkinson's Disease drug candidate, code-named "KM-819." KM-819 is an orally active ... took place in South Korea. , This Phase 1 randomized, double-blind, placebo-controlled ...
(Date:12/20/2018)... (PRWEB) , ... December 20, 2018 , ... New Year’s ... with major changes in regulations in the European Union (EU) on the horizon, Jim ... to consider. , “The transition to the EU Medical Device Regulation (MDR), digital health, ...
(Date:12/18/2018)... (PRWEB) , ... December 18, 2018 , ... Patients with ... lumpectomy have better quality of life post-treatment versus whole breast irradiation, a new study ... are typically treated with whole breast irradiation after removal of the cancerous tumor because ...
Breaking Biology Technology:
Cached News: